Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Allergy Immunotherapy for the Reduction of Asthma (AIR)

This study has suspended participant recruitment.
(No evidence of clinically meaningful benefits for asthma (reduction of asthma medication scores and symptoms) in preliminary analysis)
Sponsor:
Collaborator:
Jacobi Medical Center
Information provided by (Responsible Party):
Gabriele de Vos, Albert Einstein College of Medicine of Yeshiva University
ClinicalTrials.gov Identifier:
NCT01028560
First received: December 7, 2009
Last updated: June 29, 2015
Last verified: June 2015